CyberLiver is a Health Technology company developing Prescription Digital Therapeutic solutions for liver diseases aimed at halting or reversing the progression of Liver disease towards the decompensated cirrhosis stage, as well as providing effective means of managing the very ill cohort of patients already at this stage. A prescription digital therapeutic is a prescription-only regulated software that delivers evidence-based therapeutic intervention(s) to prevent, manage or treat a medical disorder or disease.
Why join us?
We are the world's first Prescription Digital Therapeutics company focused on providing digital solutions for Liver diseases
Strong accomplished leadership team with a passion and mission to improve the health and wellbeing of people through scientific evidence based innovations
About 11% of the world's population (844 million) suffer from chronic liver diseases with 2 million annual deaths causing an immense burden on the global healthcare system, We at CyberLiver aim to impact 15% to 20% of this population with positive outcomes through our AI-driven, Evidence-Based Digital Therapeutic Solutions
Engineering at CyberLiver
We follow Agile SCRUM Methodology and ISO 13485 based regulatory processes for software medical device development.
Interested in this company?
Skip straight to final-round interviews by applying through Triplebyte.